Surgical robotics is evolving into an AI-driven field, with Intuitive Surgical, Medtronic, and Stryker leading the market by leveraging data from robotic procedures to enhance surgeon training and predictive analytics. Intuitive Surgical showed strong growth with its da Vinci systems and digital platforms, Medtronic advanced with FDA-cleared Hugo system and cardiac solutions, while Stryker faced challenges from a cyber incident but maintained growth guidance. These companies offer investors exposure to AI in healthcare without typical software stock valuations, despite recent stock price declines.
In Q2 2026, AMD's stock surged 182.4%, driven by growth in AI workloads linked to large language models. CrowdStrike also saw strong gains of 95.6% due to a positive shift in the AI investment narrative. Conversely, Netflix's stock declined after bea...
The global blood glucose monitoring system market, valued at $16.8 billion in 2025, is projected to grow to $39.4 billion by 2035 at an 8.9% CAGR. Growth is fueled by rising diabetes prevalence, advancements in AI-enabled monitoring devices, and incr...
